Publications by authors named "F H Cafferty"

Claim this Profile
A
Acute myeloid leukaemia cells express high levels of androgen receptor but do not depend on androgen signaling for survival.
Farideh Miraki-Moud, Linda Ariza-McNaughton, Thinzar KoKo, Jad Othman, Randal Stronge, Fay Cafferty

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "Further data to enhance clinical integration of nodal hypofractionation: A commentary on the FAST-Forward nodal sub-study".
A Murray Brunt, Fay H Cafferty, Anna M Kirby, Charlotte E Coles, Judith M Bliss

Radiother Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing a 5-fraction Simultaneous Integrated Boost in Radiotherapy for Breast Cancer: The UK FAST-Forward Boost Trial Opens to Recruitment.
A M Kirby, F H Cafferty, K Poole, C Anandadas, L Bower

Clin Oncol (R Coll Radiol)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes.
Pasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, Guillermo Villacampa, Fay Cafferty

Eur Urol Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial.
Anna M Kirby, Laura Finneran, Clare L Griffin, Adrian M Brunt, Fay H Cafferty

Lancet Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis